bioinformatics software News
-
MedBiome licenses the MetaLab metaproteomic software
MedBiome is pleased to announce that it has licensed the iMetaLab software platform from the University of Ottawa. iMetaLab (imetalab.ca) is a leading bioinformatics software for metaproteomics data analysis. MedBiome uses the iMetaLab software in combination with the RapidAIM assay to identify Precision Microbiome Therapeutics that change the composition of the human microbiome, ...
-
Agilent Technologies adds new integrated biology capabilities to bioinformatics suite
Agilent Technologies Inc. (NYSE: A) today released GeneSpring 12.0, a major expansion of its popular bioinformatics software designed to enable a new level of medical science breakthroughs. With the new release, GeneSpring users can now analyze next-generation sequencing data and conduct joint analysis at the pathway level across multiple "omics" platforms in a familiar software environment. ...
-
OncoDNA Announces the Operational Launch of its OncoDEEP Kit for Comprehensive Genomic Profiling of Solid Tumors
A UNIQUE WORKFLOW SOLUTION INTEGRATING A PAN-CANCER NEXT-GENERATION SEQUENCING (NGS) PANEL POWERED BY A BIOINFORMATICS SOFTWARE SUITE FOR CUSTOMIZABLE BIOLOGICAL AND CLINICAL INTERPRETATION ONCODNA, A GENOMIC AND THERANOSTIC COMPANY SPECIALIZING IN PRECISION MEDICINE FOR THE TREATMENT OF CANCER AND GENETIC DISEASES, TODAY ANNOUNCED THE OFFICIAL LAUNCH OF THE ONCODEEP KIT DURING THE ESMO ...
By OncoDNA S.A.
-
Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service
Profacgen, a biotechnology company that offers bioinformatics platform to help academic and industrial researchers to explore, understand and analyze complex biological data in various biotechnological programs and projects, recently updated its in silico protein-protein interactions prediction service to meet diversified needs of its customers. As one of the most common molecules in cells, ...
By Profacgen
-
Profacgen Enables Custom Bioinformatics Software Development for Researchers Worldwide
Profacgen, a US-based biotechnology company, recognizing the importance of computational technologies for pursuing advanced research in modern biology, released custom bioinformatics software development to offer support for both academic and industrial researchers to explore, understand and analyze complex biological data in a variety of biotechnology programs and projects. Bioinformatics ...
By Profacgen
-
CD ComputaBio Releases AutoDock Vina Software to Accelerate Molecular Docking Projects
CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as providing access to the latest software, technologies, and expertise with competitive prices and fast turnarounds for researchers. The company has recently announced the introduction of its Autodock Vina software, designed to predict the mechanism of small ...
-
OncoDNA Launches OncoDEEP® Kit for Comprehensive Biomarker Testing of Solid Tumors
UNIQUE WORKFLOW SOLUTION INTEGRATING A COMPRENSIVE PAN-CANCER NGS PANEL POWERED BY TWIST BIOSCIENCE AND A BIOINFORMATICS SOFTWARE SUITE ONCODNA, A GENOMIC AND THERANOSTIC COMPANY SPECIALIZING IN PRECISION MEDICINE FOR THE TREATMENT OF CANCER AND GENETIC DISEASES, ANNOUNCED TODAY THE LAUNCH OF THE ONCODEEP KIT. THE KIT OFFERS A COMPLETE WORKFLOW SOLUTION WHICH ENABLES LABORATORIES WITH NGS ...
By OncoDNA S.A.
-
CD BioGlyco Launches New Glycosyl Derivatization Service for Research Use
CD BioGlyco, a biotechnology company dedicated to developing a one-stop service in the field of glycomics, now provides professional and high-quality glycan derivatization services to give scientific assistance for researchers in need. Carbohydrates only absorb light at low wavelengths, which makes UV and fluorescence detection less sensitive. Additionally, low sensitivity in glycan analysis is ...
By CD BioGlyco.
-
Agilent Technologies Expands Catalog of SureFISH Break-Apart Probes
Agilent Technologies Inc. (NYSE: A) today introduced SureFISH ALK, ROS1 and RET break-apart translocation probes, expanding its offering of oligonucleotide-based fluorescent in situ hybridization (FISH) products. Agilent now offers more than 450 FISH probes The majority of FISH probes available on the market use BAC technology. BAC probes target repeat regions, and probe choices are limited by ...
-
Agilent Technologies SureSelect Target Enrichment Now Available for Ion Proton Next-Generation Sequencing Systems
Agilent Technologies Inc. (NYSE: A) today introduced a new SureSelect target enrichment solution that allows Ion Proton users to realize the full power of their next-generation sequencers with the industry's leading human exome and custom DNA target enrichment solutions. SureSelect target enrichment is now available for all major sequencing platforms, enabling researchers to achieve the ...
-
Agilent Introduces CGH+SNP cancer microarrays and Cytogenomics software for cancer research
Agilent Technologies Inc., (NYSE: A) today introduced SurePrint G3 CGH+SNP cancer catalog microarrays, addressing the growing need of researchers to detect both copy number and copy-neutral aberrations in cancer tissue samples in the same experiment. The new microarray release is accompanied by the release of Agilent CytoGenomics 2.0 software, which now includes support for CGH+SNP analysis of ...
-
Agilent Technologies Joins Forces with Baylor College of Medicine to Provide Customized CGH Microarrays for Cancer, Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable ...
-
Great Basin and Rice University Announce Collaboration to Optimize the Design of SARS-CoV-2 Molecular Assays
Great Basin Scientific, a molecular diagnostics company, and Dr. Todd Treangen’s bioinformatics group in the Department of Computer Science at Rice University (www.treangenlab.com), today announced a co-development partnership that is optimizing the design and in silico evaluation of molecular detection assays for the SARS-CoV-2 viral RNA, the pathogen that causes COVID-19. The aim of the ...
-
SeqOne Genomics closes €20M series A to accelerate the deployment of its genomic medicine platform
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in ...
-
Immunai Recognized by Fast Company’s 2021 World Changing Ideas Awards
Immunai, a New York and Tel Aviv-based biotech company, today announced that it has been recognized as part of Fast Company’s World Changing Ideas Awards. The awards honor the businesses, policies, projects, and concepts that are actively engaged and deeply committed to pursuing innovation when it comes to solving health and climate crises, social injustice, or economic inequality. Immunai ...
By Immunai
-
Creative Enzymes Upgrades Metabolic Flux Analysis to Accelerate Your Project
Creative Enzymes, a professional enzyme preparation and service supplier based in New York, USA, is always committed to research and testing in order to provide customers with high-quality enzyme services and products. Recently, the product manager of Creative Enzymes announced the technological upgrade of the Metabolic Flux Analysis service to quantify fluxes in both prokaryotic and eukaryotic ...
-
Thermo Fisher Scientific to Bring One-Day Genomic Profiling to Hematology Oncology
Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious and time-consuming workflow. To simplify and accelerate the genomic profiling process, Thermo Fisher Scientific announced that the Ion Torrent Oncomine Myeloid Research Assay* will be available in 2020 to run on the newly ...
-
Prof. Dr. med. Michael Schmitt, MHBA has joined Ardigen`s Scientific Board to support the development of AI platforms for cell therapy discovery
Ardigen, one of the world-leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, is proud to announce that Prof. Dr. Michael Schmitt, MHBA, has joined the company’s Scientific Advisory Board. His knowledge and experience will support work on artificial intelligence-based platforms, dedicated to accelerating and optimizing the discovery of novel cell ...
By Ardigen
-
Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform
Immunai, a New York-based biotech company, today announced a $215M Series B, increasing the company’s total funding to date to $295M. The new capital will be used to expand Immunai’s “drug actuary” platform for target validation and evaluation. “We have made great progress towards our core mission of understanding the immune system, which we believe is essential to ...
By Immunai
-
Agilent Technologies and national university of singapore sign research collaboration agreement for lipidomics research
Agilent Technologies Inc. (NYSE: A) and the National University of Singapore (NUS) today announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states. Under the terms of the agreement, Agilent's provision of sophisticated test and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you